Weiss Multi-Strategy Advisers’s Pfizer PFE Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-107,800	Closed	-$3.1M	–	347
2023 Q4	$3.1M	Sell	107,800 -42,200	-28%	-$1.28M	0.07%	310
2023 Q3	$4.98M	Buy	150,000 +50,000	+50%	+$1.77M	0.12%	232
2023 Q2	$3.67M	Buy	+100,000	New	+$3.89M	0.07%	355
2020 Q2	–	Sell	-9,486	Closed	-$294K	–	603
2020 Q1	$294K	Buy	+9,486	New	+$323K	0.01%	370
2015 Q4	–	Sell	-147,560	Closed	-$4.4M	–	440
2015 Q3	$4.4M	Buy	147,560 +42,160	+40%	+$1.35M	0.19%	109
2015 Q2	$3.35M	Buy	105,400 +79,050	+300%	+$2.58M	0.13%	182
2015 Q1	$870K	Sell	26,350 -28,985	-52%	-$922K	0.04%	331
2014 Q4	$1.64M	Sell	55,335 -55,335	-50%	-$1.59M	0.06%	238
2014 Q3	$3.1M	Buy	+110,670	New	+$3.11M	0.08%	252
2013 Q3	–	Sell	-795,770	Closed	-$21.1M	–	977
2013 Q2	$21.1M	Buy	+795,770	New	+$22M	0.62%	34

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Weiss Multi-Strategy Advisers's PFE Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Pfizer (PFE) in Q1 2024, closing a stake of 91,562 shares — an estimated $2.64M sold.

Weiss Multi-Strategy Advisers first reported a position in PFE in Q3 2013 and held it in 10 quarters. The position peaked at $4.42M in Q4 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 91,562 Pfizer shares in Q1 2024, an estimated $2.64M.
Weiss Multi-Strategy Advisers first reported a position in Pfizer in Q3 2013 and held it in 10 quarters.
Weiss Multi-Strategy Advisers's Pfizer position peaked at $4.42M in Q4 2022.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.